Bibliographic Details
| Title: |
Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| Authors: |
Balakumar Chandrasekaran, Muthupandian Saravanan |
| Source: |
Frontiers in Pharmacology, Vol 14 (2023) |
| Publisher Information: |
Frontiers Media S.A., 2023. |
| Publication Year: |
2023 |
| Collection: |
LCC:Therapeutics. Pharmacology |
| Subject Terms: |
COVID-19, kinase inhibitors, cancer, hepatocellular carcinoma, JAKs, FDA, Therapeutics. Pharmacology, RM1-950 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1663-9812 |
| Relation: |
https://www.frontiersin.org/articles/10.3389/fphar.2023.1229673/full; https://doaj.org/toc/1663-9812 |
| DOI: |
10.3389/fphar.2023.1229673 |
| Access URL: |
https://doaj.org/article/2e0fb99f80ae4127adb74e25b87740c0 |
| Accession Number: |
edsdoj.2e0fb99f80ae4127adb74e25b87740c0 |
| Database: |
Directory of Open Access Journals |
